{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T16:38:10Z","timestamp":1774802290932,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,6,23]],"date-time":"2005-06-23T00:00:00Z","timestamp":1119484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,6,23]],"date-time":"2005-06-23T00:00:00Z","timestamp":1119484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Over-prescribing of benzodiazepines appears common in many countries, a better understanding of prescribing practices and attitudes may help develop strategies to reduce prescribing. This study aimed to evaluate benzodiazepine prescribing behaviour and attitudes in general practitioners practising in Chiang Mai and Lampoon, Thailand.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Questionnaire survey of general practitioners in community hospitals, to estimate: i) use of benzodiazepines for anxiety\/insomnia, panic disorder, depression, essential hypertension, and uncomplicated low back pain and ii) views on the optimal duration of benzodiazepine use.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Fifty-five of 100 general practitioners returned the completed questionnaires. They reported use of benzodiazepines for anxiety\/insomnia (n = 51, 93%), panic disorder (n = 43, 78%), depression (n = 26, 43%), essential hypertension (n = 15, 27 %) and uncomplicated low back pain (n = 10, 18%). Twenty-eight general practitioners would prescribe benzodiazepines for non-psychiatric conditions, 17 for use as muscle relaxants. Seventy-five per cent, 62% and 29% of the general practitioners agreed or totally agreed with the use of benzodiazepines for insomnia, anxiety and depression, respectively. Practitioners agreed that prescribing should be less than one week (80%); or from 1 week to 1 month (47%); or 1 to 4 months (16%); or 4 to 6 months (5%) or more than 6 months (2%). Twenty-five general practitioners (45%) accepted that they used benzodiazepines excessively in the past year.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>A considerable proportion of general practitioners in Chiang Mai and Lampoon, Thailand inappropriately use benzodiazepines for physical illnesses, especially essential hypertension and uncomplicated low back pain. However, almost half of them thought that they overused benzodiazepines. General practitioner's lack of time, knowledge and skills should be taken into account in improving prescribing behaviour and attitudes.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2296-6-27","type":"journal-article","created":{"date-parts":[[2005,6,23]],"date-time":"2005-06-23T18:13:40Z","timestamp":1119550420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand"],"prefix":"10.1186","volume":"6","author":[{"given":"Manit","family":"Srisurapanont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Garner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahathai","family":"Wongpakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,6,23]]},"reference":[{"key":"106_CR1","volume-title":"Benzodiazepines: risks, benefits or dependence \u2013 a re-evaluation (Council Report CR 59)","author":"Royal College of Psychiatrists","year":"1997","unstructured":"Royal College of Psychiatrists: Benzodiazepines: risks, benefits or dependence \u2013 a re-evaluation (Council Report CR 59). 1997, London: Royal College of Psychiatrists"},{"key":"106_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/bmj.280.6218.910","volume":"280","author":"Committee on the review of medicines","year":"1980","unstructured":"Committee on the review of medicines: Systematic review of the benzodiazepines. BMJ. 1980, 280: 910-912.","journal-title":"BMJ"},{"key":"106_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00004714-198806000-00002","volume":"8","author":"BH Uhlenhuth","year":"1988","unstructured":"Uhlenhuth BH, DeWit H, Balter MB, Johanson CE, Mellinger GD: Risks and benefits of long-term benzodiazepine use. J Clin Psychopharmacol. 1988, 8: 161-167.","journal-title":"J Clin Psychopharmacol"},{"key":"106_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/bmj.326.7391.700","volume":"326","author":"A Tonks","year":"2003","unstructured":"Tonks A: Extracts from \"Best Treatments\": treating generalized anxiety disorder. BMJ. 2003, 326: 700-702. 10.1136\/bmj.326.7391.700.","journal-title":"BMJ"},{"key":"106_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1023\/A:1008636707219","volume":"20","author":"R van Hulten","year":"1998","unstructured":"van Hulten R, Leufkens HG, Bakker A: Usage patterns of benzodiazepines in a Dutch community: a 10 year follow up. Pharm World Sci. 1998, 20: 78-82. 10.1023\/A:1008636707219.","journal-title":"Pharm World Sci"},{"key":"106_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1034\/j.1600-0447.2000.102006429.x","volume":"102","author":"WJ Naja","year":"2000","unstructured":"Naja WJ, Pelissolo A, Haddad RS, Baddoura R, Baddoura C: A general population survey on patterns of benzodiazepine use and dependence in Lebanon. Acta Psychiatr Scand. 2000, 102: 429-431. 10.1034\/j.1600-0447.2000.102006429.x.","journal-title":"Acta Psychiatr Scand"},{"key":"106_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1081\/JA-100104489","volume":"36","author":"F Kapczinski","year":"2001","unstructured":"Kapczinski F, Amaral OB, Madruga M, Quevedo J, Busnello JV, de Lima MS: Use and misuse of benzodiazepines in Brazil: a review. Subst Use Misuse. 2001, 36: 1053-1069. 10.1081\/JA-100104489.","journal-title":"Subst Use Misuse"},{"key":"106_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00004714-199610000-00004","volume":"16","author":"UE Busto","year":"1996","unstructured":"Busto UE, Ruiz I, Busto M, Gacitua A: Benzodiazepine use in Chile: impact of availability on use, abuse, and dependence. J Clin Psychopharmacol. 1996, 16: 363-372. 10.1097\/00004714-199610000-00004.","journal-title":"J Clin Psychopharmacol"},{"key":"106_CR9","first-page":"262","volume":"40","author":"BL Horta","year":"1994","unstructured":"Horta BL, de Lima MS, Faleiros JJ, Weiderpass E, Horta RL: Benzodiazepines: prescription study in a primary health care unit. Revista da Associacao Medica Brasileira. 1994, 40: 262-264.","journal-title":"Revista da Associacao Medica Brasileira"},{"key":"106_CR10","unstructured":"Chuyana N, Garner P: Primary care nurses using guidelines in Thailand: a randomised controlled trial. in submission"},{"key":"106_CR11","first-page":"316","volume":"43","author":"R Saipanish","year":"1998","unstructured":"Saipanish R, Zartrungpak S, Silpakit C: A survey of psychotropic drug prescription of general practitioners in primary care settings. Journal of the Psychiatric Association of Thailand. 1998, 43: 316-324. in Thai","journal-title":"Journal of the Psychiatric Association of Thailand"},{"key":"106_CR12","volume-title":"World Health Report 2001","author":"World Health Organization","year":"2001","unstructured":"World Health Organization: World Health Report 2001. 2001, Geneva: World Health Organization"},{"key":"106_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/heapol\/17.3.288","volume":"17","author":"B Trap","year":"2002","unstructured":"Trap B, Hansen EH, Hogerzeil HV: Prescription habits of dispensing and non-dispensing doctors in Zimbabwe. Health Policy Plan. 2002, 17: 288-295. 10.1093\/heapol\/17.3.288.","journal-title":"Health Policy Plan"},{"key":"106_CR14","first-page":"31","volume":"15","author":"H Pozenel","year":"1977","unstructured":"Pozenel H, Buckert A, Amrein R: The antihypertensive effect of lexotan (bromazepam) \u2013 a new benzodiazepine derivative. Int J Clin Pharmacol Biopharm. 1977, 15: 31-39.","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"106_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1176\/ajp.134.6.656","volume":"134","author":"L Lasagna","year":"1977","unstructured":"Lasagna L: The role of benzodiazepines in nonpsychiatric medical practice. Am J Psychiatry. 1977, 134: 656-658.","journal-title":"Am J Psychiatry"},{"key":"106_CR16","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1097\/01.BRS.0000090503.38830.AD","volume":"28","author":"MW Van Tulder","year":"2003","unstructured":"Van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM: Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the Cochrane Collaboration. Spine. 2003, 28: 1978-1992. 10.1097\/01.BRS.0000090503.38830.AD.","journal-title":"Spine"},{"key":"106_CR17","first-page":"1097","volume":"118","author":"C Krogh","year":"1978","unstructured":"Krogh C, McLean WM, LaPierre YD: Minor transquillizers in somatic disorders. Can Med Assoc J. 1978, 118: 1097-1108.","journal-title":"Can Med Assoc J"},{"key":"106_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0277-9536(99)00133-1","volume":"49","author":"P Bendtsen","year":"1999","unstructured":"Bendtsen P, Hensing G, McKenzie L, Stridsman AK: Prescribing benzodiazepines \u2013 a critical incident study of a physician dilemma. Soc Sci Med. 1999, 49: 459-467. 10.1016\/S0277-9536(99)00133-1.","journal-title":"Soc Sci Med"},{"key":"106_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0140-6736(03)12119-8","volume":"361","author":"V Patel","year":"2003","unstructured":"Patel V, Chisholm D, Rabe-Hesketh S, Dias-Saxena F, Andrew G, Mann A: Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial. Lancet. 2003, 361: 33-39. 10.1016\/S0140-6736(03)12119-8.","journal-title":"Lancet"},{"key":"106_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0165-0327(00)00254-8","volume":"65","author":"TA Furukawa","year":"2001","unstructured":"Furukawa TA, Streiner DL, Young LT: Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. J Affect Disord. 2001, 65: 173-177. 10.1016\/S0165-0327(00)00254-8.","journal-title":"J Affect Disord"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-6-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2296-6-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-6-27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-6-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:36:56Z","timestamp":1728304616000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/1471-2296-6-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,23]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1186\/1471-2296-6-27","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,23]]},"assertion":[{"value":"22 November 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}